ClinicalTrials.Veeva

Menu

The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Ovarian Cancer

Treatments

Other: Biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT03846856
HYMC-0080-18

Details and patient eligibility

About

The aim of this study is to evaluate the insulin-like growth factor (IGF) axis involvement in the immune tumor microenvironment in ovarian cancer.

Enrollment

40 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women diagnosed with epithelium ovarian cancer who have undergone surgery

Exclusion criteria

  • Pregnant women

Trial design

40 participants in 1 patient group

Ovarian cancer patients
Description:
Biopsy will be taken from ovarian cancer patients and sent to laboratory for analysis
Treatment:
Other: Biopsy

Trial contacts and locations

1

Loading...

Central trial contact

Hagit Stolz, DVM

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems